On a per-share basis, the Wilmington, Delaware-based company said it had net income of 81 cents. Earnings, adjusted for non-recurring costs, were $1.05 per share.
The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for earnings of $1.05 per share.
The chemical company posted revenue of $1.46 billion in the period.
For the year, the company reported profit of $995 million, or $5.45 per share. Revenue was reported as $6.64 billion.
Chemours shares have increased 37 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $38.69, a fall of 21 percent in the last 12 months.